Zum Hauptinhalt springen
Hochschulbibliothek der Hochschule Düsseldorf

Suchergebnisse

Katalog

Mehr
64 Treffer

Suchmaske

Suchtipp für den Bereich Mehr: Wörter werden automatisch mit UND verknüpft. Eine ODER-Verknüpfung erreicht man mit dem Zeichen "|", eine NICHT-Verknüpfung mit einem "-" (Minus) vor einem Wort. Anführungszeichen ermöglichen eine Phrasensuche.
Beispiele: (burg | schloss) -mittelalter, "berufliche bildung"

Das folgende Suchfeld wird hier nicht unterstützt: "Signatur".

Suchergebnisse einschränken oder erweitern

Aktive Suchfilter

Erscheinungszeitraum

Mehr Treffer

Weniger Treffer

Art der Quelle

Thema

Sprache

Geographischer Bezug

Inhaltsanbieter

64 Treffer

Sortierung: 
  1. Detailansicht für Treffer 1 öffnen
    Findings from Emory University Reveals New Findings on Multiple Myeloma (Optimizing Autologous Stem Cell Collections for Patients With Multiple Myeloma Receiving G-csf and Plerixafor: a Single Center Project).
    In: Stem Cell Week, 2024-06-17, S. 302-302
    serialPeriodical
    Wie komme ich dran?
  2. Detailansicht für Treffer 2 öffnen
    Data on Multiple Myeloma Described by Researchers at Mayo Clinic Arizona (Stem Cell Mobilization Yields With Daratumumab- and Lenalidomide-containing Quadruplet Induction Therapy In Newly Diagnosed Multiple Myeloma: Findings From the Master and...).
    In: Stem Cell Week, 2023-07-20, S. 188-188
    serialPeriodical
    Wie komme ich dran?
  3. Detailansicht für Treffer 3 öffnen
    Researchers' Work from Washington University Focuses on Multiple Myeloma (Motixafortide and G-csf To Mobilize Hematopoietic Stem Cells for Autologous Transplantation In Multiple Myeloma: a Randomized Phase 3 Trial).
    In: Stem Cell Week, 2023-07-20, S. 857-857
    serialPeriodical
    Wie komme ich dran?
  4. Detailansicht für Treffer 4 öffnen
    Researchers from University of Texas MD Anderson Cancer Center Report Details of New Studies and Findings in the Area of Multiple Myeloma (Outcomes of Autologous Stem Cell Transplantation In Patients With Ultra-high-risk Multiple Myeloma).
    In: Stem Cell Week, 2024-01-23, S. 617-617
    serialPeriodical
    Wie komme ich dran?
  5. Detailansicht für Treffer 5 öffnen
    Data on B-Cell Lymphoma Reported by Researchers at Bristol-Myers Squibb Company (Estimating the Cost Per Clinical Outcome of Second-line Liso-cel Versus Autologous Stem Cell Transplantation In Patients With Transplantation-intended...).
    In: Stem Cell Week, 2024, S. 156-156
    serialPeriodical
    Wie komme ich dran?
  6. Detailansicht für Treffer 6 öffnen
    Investigators at Medical University of South Carolina Report Findings in Multiple Myeloma [Daratumumab, Pomalidomide, and Dexamethasone (Dpd) Followed By High Dose Chemotherapy-autologous Stem Cell Transplantation Leads To Superior Outcomes When...].
    In: Stem Cell Week, 2023-05-25, S. 250-250
    serialPeriodical
    Wie komme ich dran?
  7. Detailansicht für Treffer 7 öffnen
    Findings from University of North Carolina Chapel Hill Yields New Findings on Lymphoma (Anti-cd30 Car T Cells As Consolidation After Autologous Haematopoietic Stem-cell Transplantation In Patients With High-risk Cd30+lymphoma: a Phase 1 Study).
    In: Stem Cell Week, 2024-06-25, S. 432-432
    serialPeriodical
    Wie komme ich dran?
  8. Detailansicht für Treffer 8 öffnen
    Studies from Dana-Farber Cancer Institute Update Current Data on Multiple Myeloma (Differentiation of Bcma-specific Induced Pluripotent Stem Cells Into Rejuvenated Cd8ab<superscript>+</superscript> T Cells Targeting Multiple Myeloma).
    In: Stem Cell Week, 2024-06-13, S. 1296-1296
    serialPeriodical
    Wie komme ich dran?
  9. Detailansicht für Treffer 9 öffnen
    Findings on Mantle Cell Lymphoma Discussed by Investigators at Memorial Sloan-Kettering Cancer Center (Immunochemotherapy Plus Lenalidomide for High-risk Mantle Cell Lymphoma With Measurable Residual Disease Evaluation).
    In: Stem Cell Week, 2024-05-09, S. 903-903
    serialPeriodical
    Wie komme ich dran?
  10. Detailansicht für Treffer 10 öffnen
    Findings on Multiple Myeloma Reported by Investigators at Mayo Clinic (Is There Still a Role for Stem Cell Transplantation In Multiple Myeloma?).
    In: Stem Cell Week, 2024-05-09, S. 327-327
    serialPeriodical
    Wie komme ich dran?
  11. Detailansicht für Treffer 11 öffnen
    New Non-Hodgkin Lymphoma Study Findings Have Been Reported from University of Utah (Allogeneic Stem Cell Transplantation and Car-t In B-cell Non-hodgkin Lymphoma: a Two-center Experience and Review of the Literature).
    In: Stem Cell Week, 2024-04-18, S. 1545-1545
    serialPeriodical
    Wie komme ich dran?
  12. Detailansicht für Treffer 12 öffnen
    New Multiple Myeloma Study Findings Have Been Reported by Investigators at University of Texas MD Anderson Cancer Center (Impact of Revised International Staging System 2 Risk Stratification On Outcomes of Patients With Multiple Myeloma...).
    In: Stem Cell Week, 2024-04-12, S. 534-534
    serialPeriodical
    Wie komme ich dran?
  13. Detailansicht für Treffer 13 öffnen
    New Non-Hodgkin Lymphoma Findings from University of Texas MD Anderson Cancer Center Reported (Ex Vivo Expanded Cord Blood Natural Killer Cells Combined With Rituximab and High-dose Chemotherapy and Autologous Stem Cell Transplantation for B...).
    In: Stem Cell Week, 2024-03-28, S. 1626-1626
    serialPeriodical
    Wie komme ich dran?
  14. Detailansicht für Treffer 14 öffnen
    New Findings from Medical College of Wisconsin in the Area of Multiple Myeloma Reported [Autologous Stem Cell Boost Improves Persistent Immune Effector Cell Associated Hematotoxicity Following Bcma Directed Chimeric Antigen Receptor T (Car T)...].
    In: Stem Cell Week, 2024-03-24, S. 579-579
    serialPeriodical
    Wie komme ich dran?
  15. Detailansicht für Treffer 15 öffnen
    Recent Findings from Memorial Sloan-Kettering Cancer Center Has Provided New Information about Non-Hodgkin Lymphoma (Reduced-intensity Compared To Nonmyeloablative Conditioning In Patients With Non-hodgkin Lymphoma Undergoing Allogeneic...).
    In: Stem Cell Week, 2024-03-11, S. 490-490
    serialPeriodical
    Wie komme ich dran?
  16. Detailansicht für Treffer 16 öffnen
    University of Virginia Reports Findings in Multiple Myeloma (The Impact of Social Vulnerability Index On Survival Following Autologous Stem Cell Transplant for Multiple Myeloma).
    In: Stem Cell Week, 2024-02-29, S. 1470-1470
    serialPeriodical
    Wie komme ich dran?
  17. Detailansicht für Treffer 17 öffnen
    New Multiple Myeloma Study Findings Recently Were Reported by Researchers at University of Texas MD Anderson Cancer Center (Impact of Pretransplant Minimal Residual Disease In Patients With Multiple Myeloma and a Very Good Partial Response or...).
    In: Stem Cell Week, 2024-01-23, S. 343-343
    serialPeriodical
    Wie komme ich dran?
  18. Detailansicht für Treffer 18 öffnen
    Reports from University of Miami Provide New Insights into Multiple Myeloma (Cryopreservation and Storage Patterns of Hematopoietic Progenitor Stem Cells for Multiple Myeloma).
    In: Stem Cell Week, 2024-01-16, S. 296-296
    serialPeriodical
    Wie komme ich dran?
  19. Detailansicht für Treffer 19 öffnen
    Data on Lymphoma Described by Researchers at University of Utah (Effect of Cumulative Dose of Brentuximab Vedotin Maintenance In Relapsed/refractory Classical Hodgkin Lymphoma After Autologous Stem Cell Transplant: an Analysis of Real-world...).
    In: Stem Cell Week, 2024-01-09, S. 238-238
    serialPeriodical
    Wie komme ich dran?
  20. Detailansicht für Treffer 20 öffnen
    Study Data from University of Arkansas for Medical Sciences Update Understanding of Multiple Myeloma (Application of R2-iss Risk Stratification To Patients With Multiple Myeloma Treated With Autologous Stem Cell Transplants At Uams).
    In: Stem Cell Week, 2024, S. 962-962
    serialPeriodical
    Wie komme ich dran?

Weitere Bibliothekskataloge

xs 0 - 576
sm 576 - 768
md 768 - 992
lg 992 - 1200
xl 1200 - 1366
xxl 1366 -